Interleukin-1beta and interleukin-6 release by peripheral blood monocytes in head and neck cancer

O. Gallo, A. M. Gori, M. Attanasio, F. Martini, B. Giusti, M. Boddi, E. Gallina, O. Fini, R. Abbate

Research output: Contribution to journalArticlepeer-review


In patients with advanced head and neck squamous cell carcinoma (HNSC), evidence of cell-mediated immunity and monocyte functional abnormalities has been reported. We studied the production of interleukin 1 beta (IL-lbeta) and interleukin 6 (IL-6) by peripheral blood monocytes from 22 patients with HNSC (12 larynx and ten oral cavity cancers) in comparison with monocyte cytokine production of age-matched healthy subjects. Pure monocytes were incubated with and without lipopolysaccarides (LPS) (10 μg ml-1) for 4 h at 37°C and IL-lbeta and IL-6 concentrations were determined in supernatants by specific ELISA. There was no significant difference in IL-Ibeta levels in monocyte supernatants from cancer in comparison to control subjects; conversely, a higher IL-6 production by unstimulated and LPS-activated cells from HNSC patients than from controls was found. No relationship was observed between cytokine production and cancer stage. The regression analysis evidenced a significant correlation between IL-lbeta and IL-6 monocyte-release in HNSC patients and in controls, so suggesting a possible autocrine control of IL-6 production by other cytokines.

Original languageEnglish
Pages (from-to)465-468
Number of pages4
JournalBritish Journal of Cancer
Issue number3
Publication statusPublished - Sep 1993

ASJC Scopus subject areas

  • Oncology
  • Cancer Research


Dive into the research topics of 'Interleukin-1beta and interleukin-6 release by peripheral blood monocytes in head and neck cancer'. Together they form a unique fingerprint.

Cite this